" According to the latest report published by Data Bridge Market Research, the Hepatocellular Carcinoma Drugs Market  CAGR Value The global hepatocellular carcinoma drugs market was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.27 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of...